23 results on '"Lars Bräuer"'
Search Results
2. The potential role of SP-G as surface tension regulator in tear film : from molecular simulations to experimental observations
- Author
-
Martin Schicht, Kamila Riedlová, Mercedes Kukulka, Wenyue Li, Aurelius Scheer, Fabian Garreis, Christina Jacobi, Friedrich Paulsen, Lukasz Cwiklik, and Lars Bräuer
- Subjects
tear film ,surfactant protein ,surface tension ,ocular surface ,dry eye ,Organic Chemistry ,General Medicine ,Lipids ,eye diseases ,Catalysis ,Computer Science Applications ,Cornea ,Inorganic Chemistry ,Tears ,Humans ,Surface Tension ,Dry Eye Syndromes ,ddc:610 ,sense organs ,Physical and Theoretical Chemistry ,Molecular Biology ,Spectroscopy - Abstract
The ocular surface is in constant interaction with the environment and with numerous pathogens. Therefore, complex mechanisms such as a stable tear film and local immune defense mechanisms are required to protect the eye. This study describes the detection, characterization, and putative role of surfactant protein G (SP-G/SFTA2) with respect to wound healing and surface activity. Bioinformatic, biochemical, and immunological methods were combined to elucidate the role of SP-G in tear film. The results show the presence of SP-G in ocular surface tissues and tear film (TF). Increased expression of SP-G was demonstrated in TF of patients with dry eye disease (DED). Addition of recombinant SP-G in combination with lipids led to an accelerated wound healing of human corneal cells as well as to a reduction of TF surface tension. Molecular modeling of TF suggest that SP-G may regulate tear film surface tension and improve its stability through specific interactions with lipids components of the tear film. In conclusion, SP-G is an ocular surface protein with putative wound healing properties that can also reduce the surface tension of the tear film.
- Published
- 2022
3. Polytetrafluoroethylene (PTFE) suture vs fiberwire and polypropylene in flexor tendon repair
- Author
-
Miriam Niederkorn, Ektor Polykandriotis, Jasmin S Gruener, Andreas Arkudas, Florian Ruppe, Elias Polykandriotis, Raymund E. Horch, and Lars Bräuer
- Subjects
Flexor tendon repair ,Polypropylenes ,Tendons ,Active motion ,chemistry.chemical_compound ,Suture (anatomy) ,Ultimate tensile strength ,Seramon® ,Materials Testing ,Fiberwire ,Cadaver ,Medicine ,Humans ,Orthopedics and Sports Medicine ,Handsurgery ,ddc:610 ,Polytetrafluoroethylene ,Polypropylene ,Sutures ,business.industry ,General Medicine ,Tendon ,Biomechanical Phenomena ,Polytetrafluoroethylene (PTFE) ,medicine.anatomical_structure ,chemistry ,Surgery ,business ,Cadaveric spasm ,Biomedical engineering - Abstract
Background In this study, we evaluate the value of novel suture material based on monofilamentous-extruded polyfluoroethylene (PTFE) compared to polypropylene (PPL) and Fiberwire (FW). Materials and methods 60 flexor tendons were harvested from fresh cadaveric upper extremities. 4–0 sutures strands were used in the PPL, FW and PTFE group. Knotting properties and mechanical characteristics of the suture materials were evaluated. A 4-strand locked cruciate (Adelaide) or a 6-strand (M-Tang) suture technique was applied as core sutures for a tendon repair. Two-way ANOVA tests were performed with the Bonferroni correction. Results Stable knotting was achieved with 5 throws with the PPL material, 7 throws for FW and 9 throws for PTFE. In the PPL group, linear tensile strength was 45.92 ± 12.53 N, in the FW group 80.11 ± 18.34 N and in the PTFE group 76.16 ± 29.10 N. FW and PTFE are significantly stronger than PPL but show no significant difference among each other. Similar results were obtained in the subgroup comparisons for different repair techniques. The Adelaide and the M-Tang knotting technique showed no significant difference. Conclusion Fiberwire showed superior handling and knotting properties in comparison to PTFE. However, PTFE allows easier approximation of the stumps. In both, M-Tang and Adelaide repairs, PTFE was equal to FW in terms of repair strength. Both PTFE and FW provide for a robust tendon repair so that early active motion regimens for rehabilitation can be applied.
- Published
- 2021
4. Anatomy in times of pandemia - Impact on teaching and body donations
- Author
-
Friedrich Paulsen, Lars Bräuer, Ingo Bechmann, Jürgen Westermann, Thomas Tschernig, Carola Meier, and Jens Waschke
- Subjects
2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Dissection ,Teaching ,General Medicine ,Body donations ,Virology ,Dissection courses ,Editorial ,Cadaver ,Humans ,Sociology ,Curriculum ,Anatomy ,Developmental Biology - Published
- 2021
5. Quantification of surfactant proteins in tears of patients suffering from dry eye disease compared to healthy subjects
- Author
-
Martin Schicht, Andreas Posa, Lars Bräuer, Fabian Garreis, Richard Dietz, Friedrich Paulsen, Saadettin Sel, Michael Scholz, Christian M. Hammer, and Ralph Sander
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Adolescent ,genetic structures ,Enzyme-Linked Immunosorbent Assay ,Disease ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Pulmonary surfactant ,Ophthalmology ,Humans ,Medicine ,Bradford protein assay ,Aged ,Total protein ,Aged, 80 and over ,business.industry ,Healthy subjects ,Pulmonary Surfactants ,General Medicine ,Middle Aged ,Healthy Volunteers ,eye diseases ,Pathophysiology ,Up-Regulation ,030104 developmental biology ,Tears ,030221 ophthalmology & optometry ,Dry Eye Syndromes ,Female ,sense organs ,Anatomy ,business ,Ocular surface ,Developmental Biology - Abstract
To quantify and compare the amounts of surfactant proteins SP-A, SP-B, SP-C and SP-D in the tear fluid collected from patients with dry eye syndrome and from individuals with a healthy ocular surface.Schirmer strips were used to collect tear fluid from both eyes of 241 volunteers (99 men, 142 women; age range: 18-87 years). Dry eye syndrome was diagnosed by ophthalmologists in 125 patients, whereas the healthy control group comprised 116 individuals. The total protein concentration was determined via Bradford assay. The relative concentration of surfactant proteins SP-A through -D was measured by enzyme-linked immuno-sorbent assay (ELISA).The mean relative concentrations of SP-A, SP-C and SP-D were significantly higher in the dry eye group as compared to the healthy controls (p0.05, one-way ANOVA). SP-B was also detected at a higher concentration in the dry eye group, but the difference to the control group was not statistically significant.The upregulation of SP-A and SP-D in the dry eye group is probably related to these proteins' known antimicrobial and immunomodulatory effects at the ocular surface. It may represent a pathophysiological response to the inflammatory condition of the ocular surface in dry eye. The upregulation of SP-B and SP-C may represent an effort of the lacrimal system to reduce surface tension and thus to counteract the increased tendency of the tear film to tear in dry eye.
- Published
- 2018
- Full Text
- View/download PDF
6. Efficacy of aflibercept (EYLEA ® ) on inhibition of human VEGF in vitro
- Author
-
W. Lamprecht, Lars Bräuer, Martin Schicht, Fabian Garreis, H. Schröder, K. Hesse, Friedrich Paulsen, and E. Naschberger
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Angiogenesis ,Pharmacology ,Umbilical vein ,Metastasis ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Medicine ,Receptor ,Aflibercept ,business.industry ,General Medicine ,Diabetic retinopathy ,Macular degeneration ,medicine.disease ,Vascular endothelial growth factor ,030104 developmental biology ,chemistry ,030221 ophthalmology & optometry ,Anatomy ,business ,Developmental Biology ,medicine.drug - Abstract
Introduction Pathological formation of blood vessels plays a key role in the growth and metastasis of tumors and also in several serious ophthalmological diseases such as wet age-related macular degeneration (AMD) or diabetic retinopathy. In AMD treatment, aflibercept (tradename EYLEA®) is used to deactivate the underlying pathological neovascularisation. Aflibercept is a recombinant fusion protein which binds to vascular endothelial growth factor (VEGF) receptors, thereby inhibiting VEGF pathway activation. VEGF is one of the most important angiogenesis factors. Objective This analysis investigates lasting efficacy of aflibercept in vitro for later application as therapeutic agent against macular degeneration (AMD). Material and methods VEGF-ELISA assays were performed to investigate binding affinities at different aflibercept concentrations. The impact of VEGF on the proliferation of human umbilical vein endothelial cells (HUVEC) was investigated using proliferation assays. Moreover, time-dependent kinetic studies were performed to analyze different aflibercept storage durations with regard to its inhibitory capabilities on human VEGF. Results and conclusion Our results reveal that aflibercept significantly lowers the amount of unbound VEGF as well as the proliferation rate of HUVEC. Moreover, in contrast to specifications given by the manufacturer, aflibercept retains its full inhibitory effect up to at least 120 h after transference from the original vial into the injection syringe.
- Published
- 2017
- Full Text
- View/download PDF
7. Altered Surfactant Protein Expression in Primary Acquired Nasolacrimal Duct Obstruction
- Author
-
Mohammad Javed Ali, Martin Schicht, Friedrich Paulsen, and Lars Bräuer
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,medicine.medical_treatment ,Dacryocystorhinostomy ,Surface-Active Agents ,Pulmonary surfactant ,Lacrimal Duct Obstruction ,Medicine ,Humans ,Nasolacrimal duct ,business.industry ,Lacrimal Apparatus ,Epithelial Cells ,General Medicine ,Middle Aged ,medicine.disease ,Lacrimal sac ,Epithelium ,Staining ,Ophthalmology ,medicine.anatomical_structure ,Nasolacrimal duct obstruction ,Immunohistochemistry ,Surgery ,Female ,Goblet Cells ,business - Abstract
Purpose To investigate the presence and distribution patterns of 6 surfactant proteins in lacrimal drainage tissues of patients with primary acquired nasolacrimal duct (NLD) obstruction. Methods The presence and distribution of surfactant proteins (SP)-G and SP-H was first assessed in normal cadaveric lacrimal systems. The study was then performed in 10 samples of lacrimal sac and the respective NLDs obtained from patients suffering from primary acquired NLD obstruction who underwent either a dacryocystorhinostomy or a dacryocystectomy. The lacrimal sac samples were further divided into fundus and body, soon after their removal. Immunohistochemical labeling was performed for assessing the presence and distribution of SPs: SP-A, SP-B, SP-C, SP-D, SP-G/SFTA2, and SP-H/SFTA3. The results were then scored as positive or negative and the distribution pattern, if any, within the lacrimal sac and NLDs was assessed. Human lung tissues were used as controls. Results SP-H was demonstrated in the lining epithelia of the normal lacrimal drainage systems, whereas SP-G was uniformly negative. Immunohistochemical labeling revealed wide variations in the staining patterns of different SPs in different regions of the lacrimal sac and the NLD. SP-D and SP-G revealed uniformly negative immunoreactivity. Variable staining patterns were also noted between the superficial and basal layers of the lining epithelia. However, the goblet cells and intraepithelial mucous glands did not express any of the SPs. Conclusions This study provides a proof of principle for the presence of SP-H and absence of SP-G in the normal lacrimal drainage systems. In cases of primary acquired nasolacrimal duct obstruction, there were alterations or loss of SP expression in the lining epithelia of the lacrimal sac and NLDs, reflecting their possible role in the etiopathogenesis of primary acquired nasolacrimal duct obstruction.In cases of primary-acquired nasolacrimal duct obstruction, the expression of multiple surfactant proteins was either deranged or lost in the lining epithelium of the lacrimal sac and nasolacrimal ducts.
- Published
- 2019
8. Surfactant proteins of the human larynx
- Author
-
Heinrich Iro, Martin Schicht, F. Kißlinger, Friedrich Paulsen, Felix Rausch, Lars Bräuer, H. Schröder, Christopher Bohr, M. Sheats, Fabian Garreis, and J. de Tristan
- Subjects
Male ,0301 basic medicine ,Larynx ,Epiglottis ,Pathology ,medicine.medical_specialty ,Pulmonary Surfactant-Associated Proteins ,education ,Biology ,03 medical and health sciences ,fluids and secretions ,0302 clinical medicine ,Western blot ,Cadaver ,otorhinolaryngologic diseases ,medicine ,Humans ,Tissue Distribution ,Subglottis ,Messenger RNA ,Innate immune system ,medicine.diagnostic_test ,General Medicine ,Mucus ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,Organ Specificity ,030221 ophthalmology & optometry ,Immunohistochemistry ,Female ,Anatomy ,Developmental Biology - Abstract
Summary Purpose Surfactant proteins (SPs) originally identified in lung tissue are important players in the innate immune system. Beyond this, they contribute to stability and rheology of gaseous or aqueous interphases. In the present study, we determined the expression and presence of SPs (A, B, C and D) in different areas of the human larynx. Methods mRNA expression of SP-A, -B, -C and -D was analyzed by means of RT-PCR in healthy samples of epiglottis, vocal and vestibular folds, subglottis and trachea. Distribution and localization of all four SPs were analyzed by Western blot and immunohistochemistry in healthy human tissue samples. Results All four SPs were detected at the mRNA- and protein level in the human larynx as well as by means of immunohistochemistry in the different tissue samples of the human larynx. Conclusion The results reveal that all four SPs are produced with different expression patterns within the human larynx. Based on the known functions, our results suggest that SPs might be involved in maintaining mucus rheology and subsequently they could be essential components for proper phonation. Moreover, the proteins seem to play a role in immune defense of the larynx.
- Published
- 2016
- Full Text
- View/download PDF
9. Recommendations of the working group of the Anatomische Gesellschaft on reduction of formaldehyde exposure in anatomical curricula and institutes
- Author
-
Johanna Plendl, Janet Weigner, Lars Bräuer, Imke Weyers, Axel Unverzagt, Stefanie Gundlach, Stephan Heermann, Martin Dokter, Daniela Fietz, Birte Steiniger, Daniela Kugelmann, Andreas Schmiedl, Ulrich Fassnacht, Andreas Winkelmann, Magdalena Müller-Gerbl, Tamás Sebestény, Bernhard Hirt, Michael L. Pretterklieber, Christoph Viebahn, Hans-Joachim Schnittler, Ute Nimtschke, Christof Schomerus, Björn Spittau, Merle Winkler, Christoph Redies, Mirko H. H. Schmidt, Ernst Voigt, Jens Waschke, Wolfram F. Neiss, Thomas Tschernig, Erich Brenner, Friedrich Paulsen, Arlette Deutsch, Martin Scaal, Süleyman Ergün, Martin Bergmann, Desalegn Tadesse Egu, and Andreas Buchhorn
- Subjects
0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Veterinary anatomy ,General Medicine ,Body weight ,3. Good health ,03 medical and health sciences ,Dissection ,Body donation ,030104 developmental biology ,Formaldehyde ,Occupational Exposure ,Practice Guidelines as Topic ,medicine ,Respiratory Hypersensitivity ,Humans ,Embalming ,030101 anatomy & morphology ,Occupational exposure limit ,Anatomy ,Intensive care medicine ,Reduction (orthopedic surgery) ,FORMALDEHYDE EXPOSURE ,Developmental Biology - Abstract
The practice of human and veterinary medicine is based on the science of anatomy and dissection courses are still irreplaceable in the teaching of anatomy. Embalming is required to preserve body donors, for which process formaldehyde (FA) is the most frequently used and well characterized biocidal substance. Since January 2016, a new occupational exposure limit (OEL) for FA of 0.37mg/m3 issued by the European Committee on Hazardous Substances is obligatory since FA has been classified as a human 1B carcinogen. The anatomical institutes in the German-speaking region are called upon to consolidate efforts to reduce use of FA in anatomical curricula and body donations. As a result, the Anatomische Gesellschaft (AG) has formed a "Working Group for Reduction of Formaldehyde Exposure in Dissection Courses" tasked with discussion and recommendation of measures to reduce FA. Based on the assessment of the Working Group, the AG has issued an official opinion to the effect that, at this point in time, embalming of body donors without FA completely is not feasible. Therefore, a combination of approaches are to be used to reduce FA exposure, including technical and structural (architectural) adaptations, modification of protocols for fixation and preservation as well as organizational measures. One structural measure considered unavoidable is the integration of air supply and exhaust of individual dissecting tables into the ventilation system of the anatomy building. To embalm human body donors, intra-arterial perfusion fixation with up to 4% FA and a total fluid volume of 150mL/kg body weight will suffice. For animals where body weights and biology of bodies vary widely (i.e. special needs of fixation for ruminants, large animals as horses) perfusion fixation with up to 4% FA and a quantity of fixative solution of 10-15% of the body weight may be required. Preservation of body donors in storage (immersion) can be done with 40% ethanol or in a full bath preservation containing up to 2% FA. Corpse humidification in the dissecting room is possible with 2% phenoxyethanol, in each case without FA. In veterinary anatomy, microbiological burden is often higher and therefore might lead to a need of FA in long-time storage. Compliance with the current OEL in all institutes would appear to be feasible in combination with various organizational measures.
- Published
- 2018
10. Expression of Surfactant Proteins in the Human Canaliculus: Evidence and Potential Insights Into the Tear Flow Dynamics
- Author
-
Nadimpalli Siva Kumar, Martin Schicht, Mohammad Javed Ali, Friedrich Paulsen, and Lars Bräuer
- Subjects
0301 basic medicine ,Male ,Cytoplasm ,Pulmonary Surfactant-Associated Proteins ,Blotting, Western ,Bone canaliculus ,Immunofluorescence ,03 medical and health sciences ,0302 clinical medicine ,Western blot ,medicine ,Cadaver ,Humans ,Eye Proteins ,Aged ,medicine.diagnostic_test ,biology ,business.industry ,Lacrimal Apparatus ,Epithelial Cells ,General Medicine ,Middle Aged ,Molecular biology ,Primary and secondary antibodies ,Immunohistochemistry ,Staining ,Ophthalmology ,030104 developmental biology ,medicine.anatomical_structure ,Lacrimal canaliculi ,Tears ,030221 ophthalmology & optometry ,biology.protein ,Surgery ,Female ,business ,Nasolacrimal Duct ,Immunostaining - Abstract
PURPOSE To investigate the presence and distribution patterns of 6 surfactant proteins (SPs) in the human lacrimal canaliculus. METHODS The study was performed on fresh frozen cadaveric samples of canaliculi. Immunohistochemical labeling was performed for assessing the presence and distribution of SP: SP-A, SP-B, SP-C, SP-D, SP-G/SFTA2, and SP-H/SFTA3. Immunofluorescence double staining was performed using the respective fluorescein-conjugated antibodies and the results were scored as positive or negative and the distribution pattern within the canalicular system was assessed. Western blot analysis was performed on the protein content which was resolved by reducing 15% sodium dodecyl sulfate-polyacrylamide electrophoresis and bands were studied following staining with primary and secondary antibodies. Human lung tissues were used as controls. RESULTS Fluorescence double staining with 4,6-diamidino 2-pheynlindole and SPs showed strong immunostaining for SP-A, SP-B, SP-C, SP-D, and SP-H/SFTA3. The positive immunofluorescence was noticed across all the layers of the epithelium but not the subepithelial structures. The expression was noted on the surfaces and superficial cytoplasm of the superficial and deep epithelial cells. There was no expression of SP-G/SFTA2 across the canalicular system. Western blot analysis of the proteins confirmed and concurred with the immunofluorescence findings. CONCLUSIONS This study provides a proof of principle for the presence of SPs known from lungs in the canalicular system and hypothesizes their possible functions and also their potential role in the tear flow dynamics between the ocular surface and the lacrimal drainage system.
- Published
- 2018
11. The distribution of human surfactant proteins within the oral cavity and their role during infectious diseases of the gingiva
- Author
-
Felix Rausch, Michael Scholz, Martin Schicht, Anselm Petschelt, Sadettin Sel, Werner Götz, Lars Bräuer, Christina Stengl, Friedrich Paulsen, Matthias Pelka, and Friedhelm Heinemann
- Subjects
Adult ,Male ,Saliva ,Blotting, Western ,Enzyme-Linked Immunosorbent Assay ,Salivary Glands ,Young Adult ,Gingivitis ,Immune system ,stomatognathic system ,Pulmonary surfactant ,Western blot ,medicine ,Humans ,Periodontitis ,Aged ,Mouth ,medicine.diagnostic_test ,Chemistry ,Proteins ,General Medicine ,Periodontium ,Middle Aged ,medicine.disease ,Immunohistochemistry ,stomatognathic diseases ,Gingival Diseases ,Immunology ,Female ,Anatomy ,medicine.symptom ,Developmental Biology - Abstract
The oral cavity with the teeth and the surrounding gingival epithelium, the periodontium, the salivary glands and other structures are open to the oral environment and thus exposed to multiple microbiological and pathogenic influences. To prevent permanent inflammatory processes such as gingivitis or periodontitis an efficient defense system is essential to ensure healthy and physiological function of the oral cavity and other interacting organic systems. Surfactant proteins (SPs), originally found in pulmonary tissue are important factors of the immune system and beyond this, support the stability and rheology of gas or fluid interfaces. This study aimed to analyze the distribution of surfactant proteins by means of Western blot and immunohistochemistry in salivary glands as well as in healthy and pathological saliva. The different expression patterns of SP-A, -B, -C and -D in healthy and pathological (periodontitis) saliva were determined using ELISA quantification. One further objective of the study was the first detection of two recent discovered proteins belonging to the surfactant protein family within human salivary glands and saliva. The results of the study reveal differences in protein expression of SP-A, -B, -C and -D within healthy and pathologic saliva. The concentration of the surfactant proteins SP-A, SP-C and SP-D is increased in saliva of people suffering from periodontal diseases, whereas by contrast, SP-B shows an opposite expression pattern. Furthermore, the results evidence the presence of SP-G and SP-H within saliva and salivary glands for the first time.
- Published
- 2015
- Full Text
- View/download PDF
12. Corrigendum to 'Recombinant expression of surfactant protein H (SFTA3) in Escherichia coli' [Ann. Anat. 208C (2016) 129-134]
- Author
-
L. Sollfrank, H. Schröder, Lars Bräuer, Martin Schicht, and Friedrich Paulsen
- Subjects
0301 basic medicine ,03 medical and health sciences ,Pulmonary surfactant ,Chemistry ,Recombinant expression ,medicine ,030101 anatomy & morphology ,General Medicine ,Anatomy ,medicine.disease_cause ,Escherichia coli ,Developmental Biology ,Microbiology - Published
- 2017
13. Detection of Surfactant Proteins A, B, C, and D in Human Nasal Mucosa and Their Regulation in Chronic Rhinosinusitis with Polyps
- Author
-
Friedrich Paulsen, Martin Schicht, Stephanie Beileke, Saadettin Sel, Stephan Knipping, Lars Bräuer, and Roman Hirt
- Subjects
Adult ,Male ,Proteases ,Adolescent ,medicine.drug_class ,Proteolipids ,medicine.medical_treatment ,Mucous membrane of nose ,Monoclonal antibody ,Young Adult ,Nasal Polyps ,Western blot ,Humans ,Immunology and Allergy ,Medicine ,Protein Precursors ,Sinusitis ,Aged ,Rhinitis ,Innate immune system ,Pulmonary Surfactant-Associated Protein A ,biology ,medicine.diagnostic_test ,Reverse Transcriptase Polymerase Chain Reaction ,business.industry ,Lactoferrin ,General Medicine ,Middle Aged ,Pulmonary Surfactant-Associated Protein D ,Immunohistochemistry ,Pulmonary Surfactant-Associated Protein C ,Immunity, Innate ,Gene Expression Regulation ,Otorhinolaryngology ,Nasal spray ,Chronic Disease ,Immunology ,biology.protein ,Female ,business - Abstract
Backround The nasal mucosa is characterized by a multirow high prismatic ciliated epithelium representing the first barrier of the immune defense system against microbial and other environmental pathogenic influences. A number of nonspecific defense mechanisms, including the presence of lactoferrin, peroxidases, proteases, interferons, and lysozymes in nasal secretions, act to counter inflammatory processes. The surfactant proteins (SPs) known from the lungs are important components of the innate immune system. They also influence the rheology of fluids and reduce the surface tension of gas–fluid interphases. The objective of this study was to investigate the protein expression of all four SPs. A specific aim was detection and characterization of SP-C, which had previously not been confirmed in human nasal mucosa. Methods The expression of mRNA for SP-A, -B, -C and -D was investigated using reverse transcriptase polymerase chain reaction on samples of both healthy nasal mucosa and nasal mucosa altered by inflammatory processes (allergic rhinitis and chronic rhinosinusitis). The distribution of all four proteins was determined with monoclonal antibodies using Western blot analysis as well as immunohistochemical methods. Results The results show that all four SPs, including SP-C not detected before this, are nasal mucosa components. A shift was also observed in the expression behavior of the SP-A, -B, and -D in nasal mucosa with inflammatory changes. Conclusion Based on these results, SPs appear to have an important function in immunologic and rheological process of the nasal mucosa and support the prospective therapeutic use of liposomal nasal sprays.
- Published
- 2013
- Full Text
- View/download PDF
14. Recombinant expression of surfactant protein H (SFTA3) in Escherichia coli
- Author
-
L. Sollfrank, Martin Schicht, Friedrich Paulsen, Lars Bräuer, and H. Schröder
- Subjects
0301 basic medicine ,Pulmonary Surfactant-Associated Proteins ,Structural similarity ,Molecular Sequence Data ,Biology ,medicine.disease_cause ,Protein Engineering ,law.invention ,03 medical and health sciences ,Pulmonary surfactant ,law ,medicine ,Protein biosynthesis ,Escherichia coli ,Humans ,Amino Acid Sequence ,Cloning, Molecular ,Peptide sequence ,Innate immune system ,030102 biochemistry & molecular biology ,General Medicine ,Protein engineering ,Recombinant Proteins ,030104 developmental biology ,Biochemistry ,Recombinant DNA ,Anatomy ,Developmental Biology - Abstract
Surfactant proteins are broadly understood to be an important structural and functional part of the lung surfactant system. These proteins influence the intra-alveolar surface tension and contribute to innate immunity of the lung. Beside the four already known surfactant proteins SP-A, SP-B, SP-C and SP-D, two novel SPs (SP-G/SFTA2 and SP-H/SFTA3) have recently been described. These show no sequential or structural similarity with the already known SPs. However, bioinformatic prediction tools suggest physicochemical properties, which have already been described for other surfactant proteins. Although it is known that SFTA2 and SFTA3 are expressed in different human tissues, their distinct functional properties remain unclear. Here, we describe the establishment of a stable expression system for recombinant SFTA3 protein synthesis in Escherichia coli. This gives rise to future experiments with the overall aim to further examine and characterize this novel protein in more detail.
- Published
- 2016
15. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines
- Author
-
D. Worlitzsch, Kristin Jäger, Saadettin Sel, Friedrich Paulsen, Ute Schulze, G. Schäfer, and Lars Bräuer
- Subjects
Lipopolysaccharides ,DNA, Complementary ,Peptidoglycan ,Biology ,Cell Line ,Proinflammatory cytokine ,Cornea ,Interferon-gamma ,medicine ,Humans ,Distribution (pharmacology) ,Inflammation ,Reverse Transcriptase Polymerase Chain Reaction ,Tumor Necrosis Factor-alpha ,Mucin ,Membrane Proteins ,Epithelial Cells ,General Medicine ,Immunohistochemistry ,Epithelium ,Cell biology ,Blot ,medicine.anatomical_structure ,Gene Expression Regulation ,CA-125 Antigen ,Immunology ,RNA ,sense organs ,Anatomy ,Conjunctiva ,Ocular surface ,Function (biology) ,Interleukin-1 ,Developmental Biology - Abstract
The aim of the present study was to evaluate the regulation of membrane-anchored mucin MUC16 by proinflammatory cytokines and bacterial components at the ocular surface. Expression and distribution of MUC16 in conjunctival (HCjE) and corneal (HCE) epithelial cell lines was monitored by RT-PCR and immunohistochemistry. To determine the regulation of MUC16, cultured HCjEs and HCEs were stimulated with different cytokines, bacterial components and bacterial supernatants, and analyzed by real-time PCR, immunodot blot and immunohistochemistry. The results indicate that MUC16 is differentially regulated between HCjEs and HCEs after challenge with inflammatory mediators and suggest shedding of MUC16 from the ocular surface epithelia into the tear film. This seems to be precisely regulated. MUC16 shedding can be differentially increased and decreased, suggesting a protective function of membrane-anchored MUC16 and supporting the hypothesis that dysregulation of membrane-anchored MUC16 at the ocular surface may be involved in dry eye pathology.
- Published
- 2008
- Full Text
- View/download PDF
16. Somatostatin supports corneal wound healing in vivo
- Author
-
Friedrich Paulsen, Paul Frömmling, Saadettin Sel, Lars Bräuer, Ivonne Schaefer, Detlev Holland, and Ulrike Hampel
- Subjects
0301 basic medicine ,Vascular Endothelial Growth Factor A ,genetic structures ,MAP Kinase Signaling System ,Octreotide ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,Downregulation and upregulation ,In vivo ,Cell Movement ,Cornea ,Burns, Chemical ,medicine ,Animals ,Sodium Hydroxide ,Cell Proliferation ,Wound Healing ,Dose-Response Relationship, Drug ,Cell growth ,General Medicine ,Anatomy ,eye diseases ,Cell biology ,Vascular endothelial growth factor ,Mice, Inbred C57BL ,Vascular endothelial growth factor A ,Eye Burns ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,sense organs ,Signal transduction ,Wound healing ,Somatostatin ,Developmental Biology - Abstract
Purpose To evaluate the influence of somatostatin (SST) and its analog octreotid (Oct) on corneal wound healing processes. Methods The wound healing rate in C57BL/6 mice eyes under SST and Oct treatment was analyzed using an alkali-induced corneal wounding model. Effects of SST and Oct on cell proliferation, migration and quantified protein expression of vascular endothelial growth factor (VEGF) on human corneal epithelial cells (HCE, cell line) were evaluated by means of electric cell-substrate impedance sensing, scratch migration assays and ELISA. ERK1/2 and p38 phosphorylation was investigated by semi-quantitative western blot analysis. Results Ten nanograms per microliters of SST significantly accelerated the wound closure rate of corneal defects in vivo. SST and Oct had no influence on HCE cell proliferation and migration and did not activate ERK1/2 or p38 signaling in HCE cells. However, there was increased VEGF protein expression in cytosolic proteins and medium supernatants of HCE upon Oct stimulation for 24 h. One and 10 ng/ml Oct led to a 2.5-fold and 100 ng/ml Oct to a 4-fold upregulation of VEGF protein expression. Conclusion The data implicate that SST promotes corneal wound healing in a mouse model. However, using a HCE cell line in vitro , the wound healing mechanism does not seem to be supported by proliferation and migration processes or by activation of ERK1/2 and p38 signaling pathways. Other possible mechanisms could be the activation of other pathways and the induction of growth factors such as VEGF that modulate the observed corneal wound healing process.
- Published
- 2015
17. Schirmer strip vs. capillary tube method: non-invasive methods of obtaining proteins from tear fluid
- Author
-
Stephanie Beileke, Andreas Posa, Friedrich Paulsen, Fabian Garreis, Martin Schicht, and Lars Bräuer
- Subjects
Adult ,Male ,medicine.medical_specialty ,Proteome ,Capillary action ,Blotting, Western ,Capillary Tubing ,Diagnostic Techniques, Ophthalmological ,Specimen Handling ,Surface-Active Agents ,Young Adult ,Pulmonary surfactant ,medicine ,Humans ,Total protein ,Chromatography ,Chemistry ,Mucin ,Non invasive ,General Medicine ,Equipment Design ,eye diseases ,Ambient air ,Surgery ,Tears ,Protein identification ,Female ,Anatomy ,Developmental Biology - Abstract
Summary Human tear fluid is a complex mixture containing over 500 solute proteins, lipids, electrolytes, mucins, metabolites, hormones and desquamated epithelial cells as well as foreign substances from the ambient air. Little is known to date about the function of most tear components. The efficient and gentle collection of tear fluid facilitates closer investigation of these matters. The objective of the present paper was to compare two commonly used methods of obtaining tear fluid, the capillary tube and Schirmer strip methods, in terms of usefulness in molecular biological investigation of tear film. The comparative protein identification methods Bradford and Western Blot were used in the analyses to this end. The surfactant proteins (SP) A–D recently described as present on the eye surface were selected as the model proteins. Both methods feature sufficient uptake efficiency for proteins in or extraction from the sampling means used (capillary tube/Schirmer strip). The total protein concentration can be determined and the proteins in the tears can be detected – besides the hydrophilic SP-A and D also the non-water-soluble proteins of smaller size such as SP-B and C. Thus both methods afford a suitable basis for comparative analysis of the physiological processes in the tear fluid of healthy and diseased subjects. On the whole, the Schirmer strip has several advantages over the capillary tube.
- Published
- 2012
18. Characterization of the mucocutaneous junction of the human eyelid margin and meibomian glands with different biomarkers
- Author
-
Fabian Garreis, Ajay Yadav, Martin Schicht, Ursula Schlötzer-Schrehardt, Friedrich Paulsen, Lars Bräuer, Ulrike Hampel, and Ozan Yüksel Tektas
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Tissue Fixation ,Meibomian gland ,Biology ,Stem cell marker ,Skin Physiological Phenomena ,medicine ,Cadaver ,Humans ,MUC1 ,Aged ,Mucous Membrane ,Stem Cells ,Mucin ,Mucins ,Eyelids ,Meibomian Glands ,General Medicine ,Middle Aged ,Immunohistochemistry ,Epithelium ,Microscopy, Electron ,medicine.anatomical_structure ,Eyelid Diseases ,Keratins ,Female ,sense organs ,Eyelid ,Anatomy ,Stem cell ,Conjunctiva ,Hair Follicle ,Biomarkers ,Developmental Biology - Abstract
Summary Purpose To investigate the morphology of the human eyelid margin and the presence of different cytokeratins, mucins and stem cell markers within the skin epithelium, mucocutaneous junction (MCJ) and palpebral conjunctiva. Methods Eyelids of body donors were investigated histologically and ultrastructurally as well as by immunohistochemical methods using antibodies to cytokeratins 1, 4, 7, 8, 10, 13, 14, 15, and 19; mucins MUC1, MUC4, and MUC5AC and potential stem cell markers K15, BCRP/ABCG2, integrin β1, and N-cadherin. Results The expression pattern of cytokeratins, mucins and stem cell markers varied across the different epithelia of the human eyelid. Within the MCJ, CK7, 15 and 19 were absent, whereas the epithelium reacted positive to antibodies to CK1, 4, 8, 10, 13 and 14. Reactivity was also observed for MUC1 and MUC4, but not for MUC5AC. No reactivity was determined for K15, BCRP/ABCG2 and integrin β1 in the area of the MCJ epithelium but a strong reactivity was present for N-cadherin. Conclusions The present immunohistochemical findings lead to a better characterization of the MCJ. Additionally, the knowledge of distribution of biomarkers like cytokeratins, mucins and stem cells can be useful in the investigation of MCJ disturbances which occur in several disorders of the meibomian glands and the lid epithelium in the course of dry eye syndrome and especially meibomian gland dysfunction.
- Published
- 2012
19. Expression analysis of ADAM17 during mouse eye development
- Author
-
Kristin Jäger, Lars Bräuer, Friedrich Paulsen, Saadettin Sel, Maja Kaiser, Isabelle Enssen, Thomas Kalinski, Norbert Nass, Stefanie Trau, and Gregor Wollensak
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Aging ,genetic structures ,Embryonic Development ,Biology ,ADAM17 Protein ,Retina ,Mice ,Gene expression ,medicine ,Animals ,Tissue Distribution ,Gene ,Corneal epithelium ,Regulation of gene expression ,Messenger RNA ,Eye morphogenesis ,Gene Expression Regulation, Developmental ,General Medicine ,eye diseases ,Cell biology ,ADAM Proteins ,medicine.anatomical_structure ,Eye development ,Female ,sense organs ,Anatomy ,Developmental Biology - Abstract
ADAM17 (a disintegrin and metallopeptidase domain 17) is crucial for eye morphogenesis. In this study we analysed the expression pattern of ADAM17 during mouse eye development. ADAM17 expression in adult retina was examined using the reverse transcription-polymerase chain reaction (RT-PCR) and verification of the RT-PCR products by DNA sequencing. Immunohistochemistry was performed to evaluate the ADAM17 expression pattern in mouse eyes at developmental stages of embryonic day (E) 12, E14, E16, E18, postnatal day (P) 0, P1, P4, P7, P14, P 30 and P175 (adult). We detected ADAM17 mRNA in adult retina tissue. ADAM17 protein was expressed in non-pigmented ciliary epithelial cells and in retinal vessels from P7 onwards during eye development. In corneal epithelial cells and endothelium, ADAM17 protein was present from P14 onwards. Although, mice in which the functional ADAM17 gene is significantly reduced develop multiple eye malformations, the expression of ADAM17 is not ubiquitous over the entire eye. Its expression pattern during development suggests that not only TNF-alpha but additional membrane-anchored substrates of ADAM17 play an important role in eye formation.
- Published
- 2011
20. Virtual microscopy-The future of teaching histology in the medical curriculum?
- Author
-
Friedrich Paulsen, M. Eichhorn, and Lars Bräuer
- Subjects
Quality Control ,Medical curriculum ,Pathology ,medicine.medical_specialty ,Microscopy ,Histology ,Multimedia ,Education, Medical ,business.industry ,Teaching ,Continuing education ,General Medicine ,computer.software_genre ,User-Computer Interface ,Microscopic Anatomy ,Germany ,medicine ,Humans ,Curriculum ,Anatomy ,business ,computer ,Virtual microscopy ,Developmental Biology - Abstract
Conventional continuing education in microscopic anatomy, histopathology, hematology and microbiology has hitherto been carried out using numerous sets of sectioned tissue specimens in a microscopy laboratory. In comparison, after digitalization of the sections it would be possible to access teaching specimens via virtual microscopy and the internet at any time and place. This would make it possible to put innumerable new learning scenarios into practice. The present article elucidates the advantages of virtual microscopy in histology instruction and presents a concept of how virtual microscopy could be introduced into the teaching of microscopic anatomy in several steps. Initially, the presently existing microscopic teaching specimens would be digitalized and made available on-line without restriction. In a second step, instruction would be shifted to an emphasis on virtual microscopy, utilizing all of the advantages offered by the technique. In a third step, the microscopic contents could be networked with other anatomical, radiological and clinical content on-line, thus opening new learning perspectives for students of human and dental medicine as well as those of medically related courses of study. The advantages and disadvantages of such a concept as well as some possibly arising consequences are discussed in the following.
- Published
- 2010
21. Enzymatic C–C-Coupling Prenylation: Bioinformatics – Modelling – Mechanism – Protein-Redesign – Biocatalytic Application
- Author
-
Diana Schulze, Roman Weber, Ludger A. Wessjohann, Wolfgang Brandt, Lars Bräuer, Julia Kufka, and Svetlana Zakharova
- Subjects
Functional role ,chemistry.chemical_classification ,Aromatic prenyltransferases ,Mechanism (biology) ,Chemistry ,Substrate specificity ,Mutagenesis (molecular biology technique) ,General Medicine ,General Chemistry ,Protein-redesign ,Terpene ,C c coupling ,Enzyme ,Biochemistry ,Prenylation ,Biocatalysis ,Terpene synthases ,QD1-999 - Abstract
The functional role of isoprenoids and especially enzymatic prenylation in nature and human application is briefly covered, with the focus on bioinformatical, mechanistical and structural aspects of prenyltransferases and terpene synthases. These enzymes are as yet underrepresented but perspectively useful biocatalysts for C–C couplings of aromatic and isoprenoid substrates. Some examples of the successful use in chemoenzymatic synthesis are given including an application for the otherwise difficult synthesis of Kuhistanol A. Computational structure-based site-directed mutagenesis can be used for rational enzyme redesign to obtain altered substrate and product specificities, which is demonstrated for terpene cyclases.
- Published
- 2009
22. Molecular and structural basis of metabolic diversity mediated by prenyldiphosphate converting enzymes
- Author
-
Eva Schulze, Wolfgang Brandt, Nils Günnewich, Julia Kufka, Diana Schulze, Svetlana Zakharova, Lars Bräuer, Ludger A. Wessjohann, Felix Rausch, and Roman Weber
- Subjects
Models, Molecular ,Stereochemistry ,Plant Science ,Horticulture ,Biochemistry ,Terpene ,chemistry.chemical_compound ,Prenylation ,Biosynthesis ,Dimethylallyltranstransferase ,Aromatic amino acids ,Stigmatella aurantiaca ,Molecular Biology ,chemistry.chemical_classification ,Alkyl and Aryl Transferases ,biology ,Chemistry ,Terpenes ,Computational Biology ,General Medicine ,biology.organism_classification ,Amino acid ,Enzyme - Abstract
General thermodynamic calculations using the semiempiric PM3 method have led to the conclusion that prenyldiphosphate converting enzymes require at least one divalent metal cation for the activation and cleavage of the diphosphate-prenyl ester bond, or they must provide structural elements for the efficient stabilization of the intermediate prenyl cation. The most important common structural features, which guide the product specificity in both terpene synthases and aromatic prenyl transferases are aromatic amino acid side chains, which stabilize prenyl cations by cation-pi interactions. In the case of aromatic prenyl transferases, a proton abstraction from the phenolic hydroxyl group of the second substrate will enhance the electron density in the phenolic ortho-position at which initial prenylation of the aromatic compound usually occurs. A model of the structure of the integral transmembrane-bound aromatic prenyl transferase UbiA was developed, which currently represents the first structural insight into this group of prenylating enzymes with a fold different from most other aromatic prenyl transferases. Based on this model, the structure-activity relationships and mechanistic aspects of related proteins, for example those of Lithospermum erythrorhizon or the enzyme AuaA from Stigmatella aurantiaca involved in the aurachin biosynthesis, were elucidated. The high similarity of this group of aromatic prenyltransferases to 5-epi-aristolochene synthase is an indication of an evolutionary relationship with terpene synthases (cyclases). This is further supported by the conserved DxxxD motif found in both protein families. In contrast, there is no such relationship to the aromatic prenyl transferases with an ABBA-fold, such as NphB, or to any other known family of prenyl converting enzymes. Therefore, it is possible that these two groups might have different evolutionary ancestors.
- Published
- 2009
23. Postmortal diagnosis of a Dyke-Davidoff-Masson syndrome in a 75-year-old woman---a case report
- Author
-
Friedrich Paulsen, Karsten Stock, Lars Bräuer, Hans-Joachim Heine, Rolf Peter Spielmann, and Dietrich Stoevesandt
- Subjects
medicine.medical_specialty ,Tonsillitis ,Hemiplegia ,Muscle hypertrophy ,Cerebral Ventricles ,Atrophy ,Fatal Outcome ,Seizures ,medicine.artery ,Cerebellum ,Intellectual Disability ,Diagnosis ,Paranasal Sinuses ,Hemiatrophy ,medicine ,Image Processing, Computer-Assisted ,Humans ,Stroke ,Cerebrum ,Aged ,business.industry ,Skull ,General Medicine ,Syndrome ,Cerebral Arteries ,medicine.disease ,Surgery ,Hemiparesis ,Paranasal sinuses ,medicine.anatomical_structure ,Female ,Anatomy ,Internal carotid artery ,medicine.symptom ,business ,Developmental Biology - Abstract
The Dyke-Davidoff-Masson syndrome is characterized by various symptoms related to hemiatrophy of the cerebrum and hypertrophy of the ipsilateral calvarium and paranasal sinuses. Clinical findings include hemiparesis or hemiplegia, seizures and/or mental retardation. The present report discusses the very unusual case of a late-diagnosed Dyke-Davidoff-Masson syndrome in a 75-year-old body donor who had suffered a left-sided stroke associated with the internal carotid artery in the course of tonsillitis at the age of 5.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.